The aim of this research is to study the obestatin signalling on in vitro heart preparations of Rana ridibunda frog using pharmacological tools dissolved in or added to 0.1% or 0.01% dimethyl sulfoxide (DMSO). The application of increasing amounts of obestatin in the concentration range 1-1000 nmol/l significantly decreased the force of contraction of excised frog hearts in the presence of 0.1% DMSO. Propranolol entirely inhibited the effect of obestatin in the presence of DMSO without affecting the amplitudes of the force of contraction. Pertussis toxin, PP2 and U0126 completely blocked the obestatininduced decrease of the force of frog heart contractions. In the presence of XE991, 10 ñmol/l obestatin had no effect on the maximal force of contraction of the same preparations. Obestatin decreased the force of contraction when applied together with an inhibitor of cAMP-dependent protein kinase (PKA). It is suggested that the negative inotropic effect of obestatin observed in the presence of 0.1% DMSO is due to neuronal KCNQ channels modulation followed by a β-adrenergic receptor-dependent and PKA-independent decrease of the contraction force. Our data reveal for the first time the participation of neuronal MAPK kinase in obestatin signalling in the heart.
for cardiac effects of obestatin are scarce. It is known that obestatin has a positive inotropic effect in excised frog hearts mediated by β-adrenergic receptors and cAMP-dependent protein kinase (PKA) [ 5 ] . Obestatin has also been shown to protect rat myocardium against injury and apoptosis induced by ischemia-reperfusion [ 2 ] . The mechanism of this action starts with specific obestatin binding to a yet unknown molecule. The latter is different from the initially proposed G-protein coupled receptor 39 [ 1 ] , which failed to be confirmed as an obestatin receptor [ 6, 7 ] . Obestatin signalling related to ischemia-reperfusion continues downstream with activation of phosphoinositide-3 kinase (PI3K), protein kinase C-ε (PKC-ε), PKC-δ and extracellular-signal regulated kinases 1 and 2 (ERK1/2) [ 2 ]. Additionally, in rat aorta and mesenteric arteries obestatin induces endothelium-dependent release of NO which is preceded by the activation of a G-protein coupled receptor, PI3K, Ca 2+ /calmodulin-dependent protein kinase II and PKA [ 8 ] .
In excised frog heart preparations, the application of 0.1% DMSO induces a positive inotropic effect mediated by the diacylglycerol-sensitive activation of transient receptor potential cation (TRPC) channels which enhance the stimulation of Ca 2+ influx [ 9 ] . Such an effect of 0.1% DMSO is very important for the correct interpretation of data obtained using lipophilic pharmacological tools like enzyme inhibitors or ion channel blockers dissolved in DMSO. Many of the substances were applied with 0.01% DMSO where the effect of the solvent was negligible.
The aim of the study was to further elucidate the signalling pathway of obestatin in frog heart using a number of inhibitors of envisaged downstream effectors some of which lipophilic, necessitating the use of DMSO.
Materials and methods. All experimental procedures were conducted in accordance with the Guiding Principles for the Care and Use of Laboratory Animals approved by the Bulgarian Center for Bioethics and conform to EU Directive 86/609/EEC.
Frog heart preparation in vitro -the experimental procedure was described in detail elsewhere [ 5, 9 ]. The manner of applying obestatin, DMSO and all blockers and inhibitors is presented in Fig. 1 . All substances were dissolved in modified Ringer solution, hereafter referred to as Ringer solution. It has the following composition -100 mmol/l NaCl, 1.3 mmol/l KCl, 0.7 mmol/l CaCl 2 and 1.2 mmol/l NaHCO 3 . 200 ñl of this solution were introduced by a cannula into the frog heart aorta. The sources of chemicals used were as follows: obestatin -from Bachem AG, Bubendorf, Switzerland; PTX (holotoxin) -from EMD Biosciences Inc., La Jolla, CA, USA; propranolol, XE991, PP2, U0126, SKF 96365, DMSO, Rp-adenosine 3 ′ ,5 ′ -cyclic monophosphorothioate (Rp-cAMPS) and all salts were from Sigma-Aldrich Inc., St. Louis, MO, USA. SEA0400 was supplied by Ferenc Fülöp.
All data are presented as means ±SEM. The n in the text refers to the number of experiments, i.e. frog heart preparations in vitro. Statistical significance was determined by Student's t test for independent samples. P < 0.05 was considered statistically significant.
Results. Low concentrations of DMSO (0.1%) significantly increase the maximal force of contraction of excised frog hearts. The effect of the repeated application of 0.01% DMSO-containing Ringer solution was negligible (Fig. 1) .
In the presence of 0.1% DMSO, increasing concentrations of obestatin significantly decreased the amplitude of the maximal force of contraction over the whole range of studied concentrations from 1 nmol/l to 1000 nmol/l ( Fig. 2A) . This negative inotropic effect is in contrast with the positive one in the absence of DMSO [ 5 ] suggesting different mechanisms of obestatin action depending on the presence of this lipophilic solvent. The negative inotropic effect of obestatin was abolished by 3 ñmol/l propranolol, a non-selective blocker of β-adrenergic receptors (Fig. 2B ). PKA-I was without significant influence on the obestatininduced negative inotropic effect when obestatin was applied at concentrations of 10, 100 and 1000 nmol/l and inhibited its effect at 1 nmol/l Obe (Fig. 2C ). Pretreatment with PTX abolished the positive inotropic effect of 0.1% DMSO and did not allow obestatin to influence significantly the maximal force of contraction as well (Fig. 2D) .
The effect of obestatin on the maximal force of heart contractions in 0.1% DMSO-containing Ringer was completely inhibited with 30 ñmol/l KB-R7943, a non-selective blocker of the Na + -Ca 2+ exchanger (Fig. 3A) . The selective NCX blocker, especially in its reverse mode, SEA0400, decreased the negative inotropic effect of obestatin at a concentration of 3 ñmol/l, while 10 µmol/l inhibited it completely ( Fig. 3C , B). However, 3 ñmol/l SEA0400 applied with 0.01% DMSORinger solution reversed the positive inotropic effect of obestatin to negative ( Fig.  3D ) as it was observed in 0.1% DMSO. The effects of inhibition of MAPK kinase, non-selective TRPC channels, KCNQ channels or Src-family tyrosine kinases on the action of obestatin were tested using 0.01% DMSO-containing Ringer solution. In the presence of PP2, an inhibitor of Src tyrosine kinase (3 ñmol/l, Fig. 4A ) and SKF 96365, a nonselective blocker of TRPC (30 ñmol/l, Fig. 4B ) obestatin increased the amplitudes of the maximal force of heart contractions. This effect was significant for 10 nmol/l and 100 nmol/l obestatin when applied with PP2, and for all studied obestatin concentrations in the presence of SKF 96365. On the other hand, in the presence of XE 991, a selective inhibitor of KCNQ-channels (10 ñmol/l, Fig.  4C ) or U0126, a MAPK kinase inhibitor (3 ñmol/l, Fig. 4D ) the addition of increasing concentrations of obestatin failed to influence significantly the force of contraction of frog heart preparations in vitro.
Discussion. The main findings of the present study are: (i) obestatin activates sympathetic neurons of excised frog heart via a Gi/o-protein and KCNQ channel-dependent mechanism and (ii) MAPK kinase participates in cardiac obestatin signalling. The preproghrelin gene is uniformly expressed in the human heart [ 10 ], as well as in the cardiomyocyte cell line HL-1 derived from adult mouse and in primary cultured human cardiomyocytes [ 11 ] . These data suggest that in the heart the levels of ghrelin and obestatin are much higher than those in blood plasma and are means ±SEM of 6 experiments. * * * P < 0.001, * * P < 0.01, * P < 0.05 that these peptides have regulatory paracrine/autocrine functions there. It was also reported that the third active component derived from preproghrelin -desacyl ghrelin -has specific binding sites and metabolic effects different from those of ghrelin in cardiomyocytes [ 12 ] . Besides, Alloatti et al. [ 2 ] showed that obestatin protects rat heart muscle cells against injury and apoptosis induced by ischemia-reperfusion. However, the role of obestatin as a regulator of heart function and the pathways involved remain largely unclear.
In excised frog heart preparations, obestatin induces a positive inotropic effect via a still unknown receptor molecule, followed by downstream activation of the Gi/o-protein and β-adrenergic receptor [ 5 ] . The blockade of propranololsensitive receptors or pertussis toxin-sensitive Gi/o-proteins inhibits the obestatininduced decrease of the maximal force of frog heart contractions obtained in the presence of 0.1% DMSO. These data confirm the participation of Gi/o-proteins and β-adrenergic receptors in obestatin signalling. The activation of cardiac β-adrenergic receptors is of great importance for the regulation of the amplitude and frequency of heart contractions. The classical mechanism mainly involves Gs-protein dependent stimulation of adenylate cyclases, which increases the level of cAMP and thus activates PKA, which has many essential downstream targets. Those include L-type Ca 2+ -channels, troponin I, phospholamban, ryanodine receptors and other molecules of the myocardium (for a more detailed discussion related to the frog heart see Sazdova et al. [ 5 ] ). We propose as a possible target for the observed regulatory effect of obestatin the Na + -Ca 2+ exchanger. In the frog heart, NCX works mainly in its reverse mode, namely as a Ca 2+ -influx mechanism during the late phase of the action potential [ 13 ] . Thus, NCX inhibition will reduce the maximal amplitude of heart contractions. It was observed that obestatin failed as a negative inotropic agent when applied with high doses of NCX inhibitors -KB-R7943 (30 ñmol/l) and SEA0400 (10 ñmol/l). however, SEA0400 at this concentration showed a much smaller counteracting effect on obestatin signalling compared to its effect at 10 ñmol/l. SEA0400 (3 ñmol/l) introduced with 0.01% DMSO-containing Ringer reversed the obestatindependent regulation in frog heart. Selective concentration of 1 ñmol/l SEA0400
[ 15 ] introduced with 0.01% DMSO also left the obestatin-induced suppression of heart contractions (data not shown). Thus the combinations of 1 or 3 ñmol/l SEA0400 and 0.01% DMSO increased the force of contraction similarly to 0.1% DMSO alone and the subsequent addition of obestatin expressed negative inotropic effect. These data suggest that the inhibition of the reverse mode of NCX has a minor or no impact on the negative inotropic effect of obestatin. Therefore, the observed obestatin-induced stimulation of β-adrenergic receptor decreases the force of frog heart contraction by a NCX-independent mechanism. We also tested the hypothesis that obestatin activates KCNQ-type voltagegated potassium channels (Kv7 channels, M-type) [ 16 ] . We applied a selective concentration of XE991 to reveal KCNQ-channels' participation in obestatin regulation of amphibian heart contraction. The presence of 10 ñmol/l XE991 removes the inotropic effect of obestatin, which strongly supports the participation of KCNQ channels in obestatin signalling. Pertussis toxin could directly block neuronal Gi/o-protein -KCNQ channel interaction [ 17 ] following the obestatinreceptor binding that activates Gi/o-protein as reported in human retinal pigment epithelial cells [ 18 ] and in human gastric cancer KATO-III cells [ 19 ] . In frog heart autonomic neurons, the latter could increase the release of adrenaline [ 5 ] . Additionally, obestatin may stimulate the myocardial M-current (KCNQ channels) via β-adrenergic receptors by a direct membrane-delimited Gi/o-protein interaction with potassium channels. It is widely accepted that β-adrenergic receptors can activate Gi/o-proteins to counteract the heart excitation process [ 20, 21 ]. The Gs-to Gi/o-protein switch-over requires an active PKA to phosphorylate the β-adrenergic receptors and thus to induce this transition [ 21 ] . Thus the disruption of PKA phosphorylation sites on the β-adrenergic receptor blocks the receptorGi/o-protein coupling [ 21 ] . However, the presence of a specific PKA inhibitor in the presence of DMSO did not prevent the obestatin-induced decrease in maximal force of contraction of excised frog hearts. Therefore, these data reject the possibility of the involvement of a PKA-dependent Gs-to Gi/o-protein switch and confirm that the sympathetic neurons are the main and possibly the only obestatin target in the heart of Rana ridibunda.
In both, human retinal pigment epithelial cells [ 18 ] and human gastric cancer cells [ 19 ] obestatin, via the Gi/o-protein, activates PI3K, PKC, non-receptor Src tyrosine kinase and ERK1/2. On the basis of our data obtained in the presence of U0126 and PP2, it can be suggested that MAPK kinase participates in obestatin signalling, while Src tyrosine kinase is not involved or its influence is not considerable. It is suggested that Src tyrosine kinase does not participate as its reported target in obestatin signalling -KCNQ channels type 1 are not phosphorylated by it in frog heart cells [ 22 ] .
